Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 13;87(6):3123-3127.
doi: 10.1097/MS9.0000000000003338. eCollection 2025 Jun.

Assessing the recurrence rate in locally advanced Luminal A patients compared to triple-negative patients in Shahid Rahimi Hospital Khorramabad in 2022: a cross-sectional study

Mohammad Joudaki  1 , Parya Khani  1 , Simin Farokhi  2   3 , Shahram Ahmadi Somaghian  4 , Sarah Rahimi  1 , Mania Beiranvand  5 , Yaser Mokhayeri  6 , Ali Pajouhi  1   3
Affiliations

Assessing the recurrence rate in locally advanced Luminal A patients compared to triple-negative patients in Shahid Rahimi Hospital Khorramabad in 2022: a cross-sectional study

Mohammad Joudaki et al. Ann Med Surg (Lond). .

Abstract

Background: Breast cancer is one of the most common causes of cancer death in women both globally and in Iran. Although medical breakthroughs have improved its prognosis, different characteristics can vary locally, especially in understudied regions. Therefore, the present study was designed and carried out in 2022 to compare the rate of breast cancer recurrence in Luminal A and triple-negative patients referred to the Shahid Rahimi Hospital in Khorramabad from March 2019 to March 2020.

Materials and methods: This study was a descriptive-analytical cross-sectional study designed and conducted on 59 patients diagnosed with Luminal A and triple-negative breast cancer treated at the Shahid Rahimi Hospital from March 2019 to March 2020. In this study, the data collection instrument was a researcher-designed form that included information such as age, history of recurrence, type of cancer, family history of cancer, personal history of cancer, lymph node involvement, hookah use history, smoking history, breastfeeding history, and material status. Finally, after collecting information, data was analyzed using SPSS software version 25.

Results: The average age of the patients in this study was 49.45 ± 6.01 years, and the youngest and oldest patients were 35 and 62 years, respectively. Among the studied patients, 34 individuals (57.63%) had Luminal A cancer, and 25 patients (42.37%) had triple negative cancer. Recurrence was reported in 23 patients (38.98%), and lymph node involvement was reported in 21 patients (35.59%). Moreover, 14 patients (23.73%) were positive for a personal history of cancer, and 22 patients (37.29%) had a family history of cancer. In this study, the relationship between recurrence and type of cancer and involvement of lymph nodes was statistically significant (P < 0.05).

Conclusion: The rate of recurrence in patients with Luminal A cancer was higher than in patients with triple-negative cancer, according to the results of the study. More attention and periodic examinations in terms of recurrence in patients with Luminal A cancer were necessary.

Keywords: Luminal A; breast cancer; malignancy; recurrence; triple-negative.

PubMed Disclaimer

Conflict of interest statement

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. The authors declare no conflict of interest.

Similar articles

See all similar articles

References

    1. Morgovan C, Dobrea CM, Butuca A, et al. . Safety profile of the trastuzumab-based ADCs: analysis of real-world data registered in eudravigilance. Biomedicines 2024;12:953. - PMC - PubMed
    1. Shaghaghi Torkdari Z, Khalaj-Kondori M, Hosseinpour Feizi MA. Plasma circulating terminal differentiation-induced non-coding RNA serves as a biomarker in breast cancer. Int J Hematol Oncol Stem Cell Res 2024;18:1–6. - PMC - PubMed
    1. Łukasiewicz S, Czeczelewski M, Forma A, et al. . Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel) 2021;13:4287. - PMC - PubMed
    1. Rezaeimanesh M, Solhi M, Azar FEF, et al. . Determinants of mammography screening in Tehranian women in 2018 based on the health belief model: a cross-sectional study. J Educ Health Promot 2021;10:119. - PMC - PubMed
    1. Gangnon RE, Stout NK, Alagoz O, et al. . Contribution of breast cancer to overall mortality for US women. Med Decis Making 2018;38:24s–31s. - PMC - PubMed

LinkOut - more resources